Can Hugan Tablets improve early-stage liver cirrhosis?

Feb 14, 2025 Source: Cainiu Health

Dr. Gao Jun

Introduction

In general, Hugan tablets can assist in improving early-stage liver cirrhosis, but cannot completely cure it. Medication use should be conducted under a doctor's guidance. Hugan tablets have the effect of reducing serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST), both of which increase when liver cells are damaged. By lowering the activity of these enzymes, Hugan tablets can alleviate liver cell damage and promote the repair and regeneration of liver cells.

Generally, Hugan tablets can assist in improving early-stage liver cirrhosis but cannot completely cure it. Medication should be used under a doctor's guidance. Detailed analysis is as follows:

Hugan tablets can lower serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST). These enzymes increase when liver cells are damaged. By reducing the activity of these enzymes, Hugan tablets can alleviate liver cell injury and promote repair and regeneration of liver cells, thereby exerting a certain therapeutic effect on early-stage liver cirrhosis caused by various factors. Additionally, Hugan tablets can relieve symptoms such as flank pain, chest tightness, and abdominal distension caused by liver qi stagnation, helping to improve blood circulation in the liver and further maintain normal liver function.

The ingredients in Hugan tablets also have functions of strengthening the spleen and aiding digestion. They can help alleviate symptoms such as spleen and stomach weakness and indigestion that may occur with liver cirrhosis. By regulating spleen and stomach function, Hugan tablets can indirectly reduce the burden on the liver and aid in its recovery. However, Hugan tablets are not intended for direct treatment of early-stage liver cirrhosis; rather, they serve as an adjunctive medication to help alleviate symptoms and promote liver recovery.

The treatment of early-stage liver cirrhosis also requires comprehensive approaches such as antiviral therapy, liver-protective therapy, and adjustments to diet and lifestyle.

View All

What does it mean if the AST/ALT ratio is 0.8, which is偏低 (low)?

In general, a low AST/ALT ratio of 0.8 may be caused by imbalanced diet, stress response after intense exercise, mild fatty liver, viral hepatitis, or liver cirrhosis. It is recommended to seek medical attention promptly, identify the underlying cause, and receive symptomatic treatment under a doctor's guidance. In daily life, maintain a regular sleep schedule, avoid staying up late and excessive fatigue, and reduce the metabolic burden on the liver.

View Full Answer

What causes the darkening of facial complexion in hepatitis B patients?

In general, a darkened complexion in patients with hepatitis B may be caused by excessive sun exposure, lack of sleep, active hepatitis B virus, liver cirrhosis, or adrenal cortical insufficiency. If discomfort symptoms occur, it is recommended to seek timely medical evaluation and treatment at a正规 hospital. In daily life, proper sun protection measures should be taken, sufficient sleep should be ensured, and hepatitis B treatment should be consistently followed as directed by a physician.

View Full Answer

What are the causes of enlarged spleen in hepatitis B carriers?

In general, splenomegaly in individuals carrying hepatitis B may be caused by physiological individual differences, long-term alcohol consumption, active hepatitis B virus, liver cirrhosis, or portal hypertension. Patients can choose appropriate management approaches such as routine care, medication, or surgical treatment based on their specific conditions. Individuals with hepatitis B should incorporate regular check-ups into their daily routine, and especially after detecting splenomegaly, need to closely monitor disease progression.

View Full Answer

Taking one tablet of entecavir does not indicate whether liver cirrhosis is in the early or late stage.

Taking only one tablet of entecavir cannot determine whether liver cirrhosis is in the early stage or intermediate to late stages. The standard recommended dose of this medication is one tablet daily, a dosage determined based on antiviral efficacy requirements and not directly related to the stage of liver cirrhosis. Therefore, the number of tablets taken cannot be used to assess the stage of disease. To accurately determine the stage of liver cirrhosis, it is recommended to seek timely medical evaluation and complete appropriate diagnostic tests.